Literature DB >> 27974205

TRPV1 Nociceptor Activity Initiates USP5/T-type Channel-Mediated Plasticity.

Patrick Stemkowski1, Agustin García-Caballero1, Vinicius De Maria Gadotti1, Said M'Dahoma1, Shuo Huang1, Stefanie Alice Gertrud Black1, Lina Chen1, Ivana Assis Souza1, Zizhen Zhang1, Gerald Werner Zamponi2.   

Abstract

Peripheral nerve injury and tissue inflammation result in upregulation of the deubiquitinase USP5, thus causing a dysregulation of T-type calcium channel activity and increased pain sensitivity. Here, we have explored the role of afferent fiber activity in this process. Conditioning stimulation of optogenetically targeted cutaneous TRPV1 expressing nociceptors, but not that of non-nociceptive fibers, resulted in enhanced expression of USP5 in mouse dorsal root ganglia and spinal dorsal horn, along with decreased withdrawal thresholds for thermal and mechanical stimuli that abated after 24 hr. This sensitization was drastically reduced by an interfering peptide that prevented USP5-Cav3.2 association. Sensitization was relieved by pharmacological block of TRPV1 afferents, but not of myelinated neurons. In spinal cord slice recordings, we could optogenetically trigger an activity-dependent potentiation of presynaptic neurotransmission in the spinal dorsal horn that relied on Cav3.2 channel activity. This neuronal-activity-induced USP5 upregulation may underlie a protective, transient sensitization of the pain pathway.
Copyright © 2016 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cav3.2; DRG; T-type; TRPV1; USP5; optogenetics; pain; spinal cord

Mesh:

Substances:

Year:  2016        PMID: 27974205     DOI: 10.1016/j.celrep.2016.11.047

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  19 in total

1.  Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity.

Authors:  Jonathan A Cohen; Tara N Edwards; Andrew W Liu; Toshiro Hirai; Marsha Ritter Jones; Jianing Wu; Yao Li; Shiqun Zhang; Jonhan Ho; Brian M Davis; Kathryn M Albers; Daniel H Kaplan
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

Review 2.  Recent advances in the development of T-type calcium channel blockers for pain intervention.

Authors:  Terrance P Snutch; Gerald W Zamponi
Journal:  Br J Pharmacol       Date:  2017-07-12       Impact factor: 8.739

Review 3.  A bright future? Optogenetics in the periphery for pain research and therapy.

Authors:  Aaron D Mickle; Robert W Gereau
Journal:  Pain       Date:  2018-09       Impact factor: 6.961

4.  Long-Term Depression Induced by Optogenetically Driven Nociceptive Inputs to Trigeminal Nucleus Caudalis or Headache Triggers.

Authors:  Bruno Pradier; Hye Bin Shin; Duk Soo Kim; Robyn St Laurent; Diane Lipscombe; Julie A Kauer
Journal:  J Neurosci       Date:  2018-07-27       Impact factor: 6.167

5.  Measuring Mouse Somatosensory Reflexive Behaviors with High-speed Videography, Statistical Modeling, and Machine Learning.

Authors:  Ishmail Abdus-Saboor; Wenqin Luo
Journal:  Neuromethods       Date:  2022-05-27

6.  TRPV1-Lineage Somatosensory Fibers Communicate with Taste Neurons in the Mouse Parabrachial Nucleus.

Authors:  Jinrong Li; Md Sams Sazzad Ali; Christian H Lemon
Journal:  J Neurosci       Date:  2022-01-13       Impact factor: 6.709

7.  The nAChR Chaperone TMEM35a (NACHO) Contributes to the Development of Hyperalgesia in Mice.

Authors:  Sergey G Khasabov; Victoria M Rogness; Montana B Beeson; Lucy Vulchanova; Li-Lian Yuan; Donald A Simone; Phu V Tran
Journal:  Neuroscience       Date:  2021-01-07       Impact factor: 3.590

Review 8.  Voltage-dependent CaV3.2 and CaV2.2 channels in nociceptive pathways.

Authors:  Lucia Hoppanova; Lubica Lacinova
Journal:  Pflugers Arch       Date:  2022-01-18       Impact factor: 3.657

9.  Preclinical assessment on neuronal regeneration in the injury-related microenvironment of graphene-based scaffolds.

Authors:  Yun Qian; Xu Wang; Jialin Song; Wei Chen; Shuai Chen; Yi Jin; Yuanming Ouyang; Wei-En Yuan; Cunyi Fan
Journal:  NPJ Regen Med       Date:  2021-06-02

10.  A modulator of the low-voltage-activated T-type calcium channel that reverses HIV glycoprotein 120-, paclitaxel-, and spinal nerve ligation-induced peripheral neuropathies.

Authors:  Song Cai; Peter Tuohy; Chunlong Ma; Naoya Kitamura; Kimberly Gomez; Yuan Zhou; Dongzhi Ran; Shreya Sai Bellampalli; Jie Yu; Shizhen Luo; Angie Dorame; Nancy Yen Ngan Pham; Gabriella Molnar; John M Streicher; Marcel Patek; Samantha Perez-Miller; Aubin Moutal; Jun Wang; Rajesh Khanna
Journal:  Pain       Date:  2020-11       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.